Diamond Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	501.49	768.25	616.1	434.84	395.2
Revenue Growth (YoY)	-34.72%	24.70%	41.68%	10.03%	28.99%
Cost of Revenue	346.25	437.54	326.5	250.53	207.32
Gross Profit	155.25	330.71	289.59	184.32	187.88
Selling, General & Admin	181.95	176.56	194.89	111.31	111.86
Research & Development	47.49	41.4	29.33	25.94	27.93
Operating Expenses	241.17	222.4	225.69	138.1	140
Operating Income	-85.93	108.31	63.91	46.22	47.88
Interest Expense	-5.19	-7.44	-7.52	-3.74	-2.27
Interest & Investment Income	2.28	1.89	0.7	0.43	0.04
Currency Exchange Gain (Loss)	-	0.33	0.08	-0.35	0.06
Other Non Operating Income (Expenses)	8.99	-2.68	1.17	-0.83	2.86
EBT Excluding Unusual Items	-79.84	100.4	58.33	41.73	48.57
Gain (Loss) on Sale of Investments	-	-	-	-	0.03
Gain (Loss) on Sale of Assets	-	-4.72	-	0.1	1.35
Other Unusual Items	-	-	-	-	2.11
Pretax Income	-79.84	95.69	58.33	41.82	52.05
Income Tax Expense	-9.53	22.49	11.59	8.44	10.13
Net Income	-70.31	73.2	46.74	33.39	41.92
Net Income to Common	-70.31	73.2	46.74	33.39	41.92
Net Income Growth	-	56.61%	39.98%	-20.35%	279.40%
Shares Outstanding (Basic)	40	38	37	36	36
Shares Outstanding (Diluted)	40	39	37	36	36
Shares Change (YoY)	2.60%	4.92%	1.02%	-0.00%	3.35%
EPS (Basic)	-1.78	1.90	1.27	0.92	1.15
EPS (Diluted)	-1.78	1.90	1.27	0.92	1.15
EPS Growth	-	49.29%	39.10%	-20.60%	269.48%
Free Cash Flow	-2.9	4.44	-155.72	84.57	-19.25
Free Cash Flow Per Share	-0.07	0.12	-4.24	2.33	-0.53
Dividend Per Share	-	0.166	0.136	0.083	0.105
Dividend Growth	-	22.01%	63.63%	-20.67%	283.21%
Gross Margin	30.96%	43.05%	47.01%	42.39%	47.54%
Operating Margin	-17.14%	14.10%	10.37%	10.63%	12.12%
Profit Margin	-14.02%	9.53%	7.59%	7.68%	10.61%
Free Cash Flow Margin	-0.58%	0.58%	-25.27%	19.45%	-4.87%
EBITDA	-57.21	131.52	91.49	73.94	79.64
EBITDA Margin	-11.41%	17.12%	14.85%	17.00%	20.15%
D&A For EBITDA	28.72	23.21	27.58	27.72	31.76
EBIT	-85.93	108.31	63.91	46.22	47.88
EBIT Margin	-17.14%	14.10%	10.37%	10.63%	12.12%
Effective Tax Rate	-	23.50%	19.88%	20.17%	19.46%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.